Forian Inc (FORA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Forian Inc (FORA) has a cash flow conversion efficiency ratio of 0.108x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.22 Million) by net assets ($29.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Forian Inc to measure how many days the company can operate on defensive assets alone.
Forian Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Forian Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Forian Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Forian Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pacific Petroleum Transportation JSC
VN:PVP
|
N/A |
|
Prakash Pipes Limited
NSE:PPL
|
0.022x |
|
Xtant Medical Holdings Inc
NYSE MKT:XTNT
|
0.106x |
|
Lark Distilling Co. Ltd
AU:LRK
|
-0.021x |
|
NS Co. Ltd
KQ:217820
|
0.071x |
|
Postmedia Network Canada Corp
TO:PNC-B
|
-0.011x |
|
ETHZilla Corporation
NASDAQ:ETHZ
|
-0.106x |
|
Kala Pharmaceuticals Inc
NASDAQ:KALA
|
-0.651x |
Annual Cash Flow Conversion Efficiency for Forian Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Forian Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see FORA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $29.78 Million | $2.89 Million | 0.097x | +929.98% |
| 2024-12-31 | $30.05 Million | $282.83K | 0.009x | -64.20% |
| 2023-12-31 | $27.72 Million | $728.82K | 0.026x | +103.81% |
| 2022-12-31 | $12.42 Million | $-8.58 Million | -0.691x | -0.80% |
| 2021-12-31 | $25.17 Million | $-17.25 Million | -0.685x | -81.64% |
| 2020-12-31 | $11.27 Million | $-4.25 Million | -0.377x | -110.27% |
| 2019-12-31 | $-281.03K | $-1.03 Million | 3.674x | -- |
About Forian Inc
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical … Read more